UPMC Physician Resources

Michael G. Risbano, MD, MA, FCCP

Michael G. Risbano, MD, MA, FCCP
Office: 
UPMC Montefiore Hospital, NW628 
3459 Fifth Avenue Pittsburgh, PA 15213 
Phone: 412-864-3199
 
Education 
MA, Medical Science, Boston University School of Medicine, 1997
MD, Boston University School of Medicine, 2002
 
Training 
Residency, Internal Medicine, Boston University Medical Center,2005 
Fellowship, Pulmonary and Critical Care, University of Colorado, Denver, 2010 Fellowship, Pulmonary Hypertension, University of Colorado, Denver, 2010
 
Research Interest 
Dr. Risbano is interested in the hemodynamic evaluation of subjects with pulmonary hypertension and correlation of hemodynamic values with biomarkers for the early diagnosis of pulmonary hypertension. Dr. Risbano is directly involved in the clinical and research exercise right heart catheterization efforts in which we identify patients with various forms of exercise pulmonary hypertension. 

He has worked closely with Dr. Mark Gladwin in the study of endothelial function in response to the infusion of aged red cells. Most recently he has published the study Effects of Aged Stored Autologous Red Blood Cells on Human Endothelial Function in the American Journal of Respiratory and Critical Care Medicine. This study demonstrated that intra-arterially infused red blood cells at the upper limits of storage impaired endothelial function, as measured by the reduced forearm blood flow responses to acetylcholine, an endothelium NO synthase-dependent vasodilator. 

Dr. Risbano is also the PI for a number of investigator initiated and Pharma related research clinical trials.
 
Clinical Interest 
Dr. Risbano is an Assistant Professor of Medicine and the Head of Clinical Operations for Pulmonary Hypertension in the Division of Pulmonary, Allergy and Critical Care Medicine at the University of Pittsburgh. Dr. Risbano’s clinical interests are primarily focused on the diagnosis, management and treatment of pulmonary hypertension. He is an attending physician in the Comprehensive Pulmonary Hypertension Program. He works with patients with all forms of pulmonary hypertension. Dr. Risbano performs right heart catheterizations to diagnose and follow the hemodynamic progression of patients with pulmonary hypertension. He is also attending Intensivist physician at Shadyside-UPMC.
 
Selected Publications:
Risbano, MG, Kanias, T, Triulzi, D, Donadee, C, Barge, S, Badlam, J, Jain, S, Belanger, AM, Kim-Shapiro, DB, Gladwin, MT. Effects of Aged Stored Autologous Red Blood Cells on Human Endothelial Function. Am J Respir Crit Care Med. 2015; 192(10): 1223-33.  
Hunt, JM, Risbano, MG, Messenger, JC, Carroll, J, Badesch, D, Lowes, BD, Casserly, IP, Kay, J, Bull, TM. Timed response to inhaled nitric oxide in pulmonary hypertension. Pulm Circ. 2014; Mar;4(1): 103-9.
 
Kapnadak, SG, Abt, D, Risbano, MC. Acute respiratory failure mimicking acute respiratory distress syndrome due to parenchymal infiltration by metastatic melanoma. Pulm Circ. 2013; Dec;3(4): 959-62.
 
Risbano, MG, Gladwin, MT. Therapeutics targeting of dysregulated redox equilibrium and endothelial dysfunction. Handb Exp Pharmacol. 2013; 218: 315-49.
 
Stamm, JA, Risbano, MG, Mathier, MA. Overview of current therapeutic approaches for pulmonary hypertension. Pulm Circ. 2011; 1(2): 138-59.
 
Risbano, MG, Meadows, CA, Coldren, CD, Jenkins, TJ, Edwards, MG, Collier, D, Huber, W, Mack, DG, Fontenot, AP, Geraci, MW, Bull, TM. Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension. Clin Transl Sci. 2010; Oct;3(5): 210-8.
 
Meadows, CA, Risbano, MG, Zhang, L, Geraci, MW, Tuder, RM, Collier, DH, Bull, TM. Increased expression of growth differentiation factor-15 in systemic sclerosis-associated pulmonary arterial hypertension. Chest. 2011; May;139(5): 994-1002.
 
Risbano, MG, Groshong, SD, Schwarz, MI. Lung nodules in a woman with a history of breast cancer. Diagnosis: a sarcoid-like reaction in metastatic breast cancer. Chest. 2007; Nov;132(5): 1697-701.
 
Felman, JA, Risbano, M, Mitchell, PM, Metha, SD, Fish, SS. Evaluating acceptance and understanding of risk in the emergency department: are all risk statements created equally?. Acad Emerg Med. 2002; Apr;9(4): 309-16.
 
Sponsored Research/Activities
Title: Slope of 6MWD Improvement as a Predictor of Clinical Outcome in PAH
Role: Principal Investigator
Funding Agency: United Therapeutics Corp.
Start Year: 2015
End Year: 2017
Title: Uric Acid Levels After Phosphodiesterase-5 Inhibition Predict Improved Outcome in Pulmonary Arterial Hypertension
Role: Principal Investigator
Funding Agency: United Therapeutics Corp.
Start Year: 2015
End Year: 2016
Title: Storage Lesion in Banked Blood due to Disruption of Nitric Oxide Hemostasis
Role: Co-Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: R01 HL098032
Start Year: 2013
End Year: 2018
Title: Vascular Subphenotypes of Lung Disease - Core C
Role: Co-Investigator
Funding Agency: National Heart, Lung, & Blood Institute
Grant Number: P01 HL103455
Start Year: 2011
End Year: 2016
 
Notable Achievements
Member, Pulmonary Hypertension Association Clinicians and Researchers, 2008-Present
Member, American Thoracic Society, 2006-Present
Member, ATS Pulmonary Circulation Program Committee, 2013-Present
PACCM Fellowship Committee Member, 2013-Present
Ad Hoc Mauscript Reviewer: Chest, Annals of ATS, COPD, Heart and Lung, Present
Pulmonary Hypertension Association Travel Award, 2010

CME Courses

Pulm/Rheum Grand Rounds Spring 2017: Pulmonary Hypertension in Systemic Sclerosis

Pulm/Rheum Grand Rounds Spring 2017: Pulmonary Hypertension in Systemic Sclerosis

Publish Date: 3/7/2017
Quick view   View the full course